Cargando…

Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program

PURPOSE: To investigate the impact of medication reconciliation (MR), through avoidance of unintentional medication discrepancies, on enhanced recovery after surgery programs designed for older patients undergoing orthopedic joint surgery.  METHOD: Our study was divided into two phases. In the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaoying, Xiao, Lei, Li, Ying, Qiu, Feng, Huang, Wei, Li, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985260/
https://www.ncbi.nlm.nih.gov/pubmed/35387676
http://dx.doi.org/10.1186/s12913-022-07884-9
_version_ 1784682331042217984
author Zheng, Xiaoying
Xiao, Lei
Li, Ying
Qiu, Feng
Huang, Wei
Li, Xinyu
author_facet Zheng, Xiaoying
Xiao, Lei
Li, Ying
Qiu, Feng
Huang, Wei
Li, Xinyu
author_sort Zheng, Xiaoying
collection PubMed
description PURPOSE: To investigate the impact of medication reconciliation (MR), through avoidance of unintentional medication discrepancies, on enhanced recovery after surgery programs designed for older patients undergoing orthopedic joint surgery.  METHOD: Our study was divided into two phases. In the first phase, MR was performed for elderly patients undergoing orthopedic joint surgery. Types of medication discrepancies and their potential risks were analyzed. In the second phase, a controlled study was conducted in a subgroup of patients diagnosed with periprosthetic joint infection (PJI) and who were scheduled for two-stage revision. The primary goal was to investigate the impact of MR on length of stay for the first stage. The secondary goal was to investigate the time between the first admission and the reimplantation of a new prosthesis, the number of readmissions within 30 days, hospitalization cost. RESULTS: A total of 506 medication discrepancies were identified in the included 260 patients. Intolerance had the highest incidence (n = 131, 25.7%). The Bayliff tool showed that 71.9% were assessed as level 2 risk, and 10.3% had a life-threatening risk. For patients with PJI, MR reduced the average length of stay in the first stage (16.3 days vs. 20.7 days, P = 0.03) and shortened the time (57.3 days vs. 70.5 days, P = 0.002) between the first admission and the reimplantation of a new prosthesis. The average cost of hospital stay ($8589.6 vs. $10,422.6, P = 0.021), antibiotics ($1052.2 vs. $1484.7, P = 0.032) and other medications ($691.5 vs. $1237.6, P = 0.014) per patient at our hospital were significantly decreased. Notably, significant improvements in patient satisfaction were seen in participants in the MR group. CONCLUSION: Through MR by clinical pharmacists, medication discrepancies within the orthopedic ERAS program could be identified. For patients with periprosthetic joint infection, better patient satisfaction and clinical and economical outcomes can be achieved with this method.
format Online
Article
Text
id pubmed-8985260
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89852602022-04-07 Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program Zheng, Xiaoying Xiao, Lei Li, Ying Qiu, Feng Huang, Wei Li, Xinyu BMC Health Serv Res Research PURPOSE: To investigate the impact of medication reconciliation (MR), through avoidance of unintentional medication discrepancies, on enhanced recovery after surgery programs designed for older patients undergoing orthopedic joint surgery.  METHOD: Our study was divided into two phases. In the first phase, MR was performed for elderly patients undergoing orthopedic joint surgery. Types of medication discrepancies and their potential risks were analyzed. In the second phase, a controlled study was conducted in a subgroup of patients diagnosed with periprosthetic joint infection (PJI) and who were scheduled for two-stage revision. The primary goal was to investigate the impact of MR on length of stay for the first stage. The secondary goal was to investigate the time between the first admission and the reimplantation of a new prosthesis, the number of readmissions within 30 days, hospitalization cost. RESULTS: A total of 506 medication discrepancies were identified in the included 260 patients. Intolerance had the highest incidence (n = 131, 25.7%). The Bayliff tool showed that 71.9% were assessed as level 2 risk, and 10.3% had a life-threatening risk. For patients with PJI, MR reduced the average length of stay in the first stage (16.3 days vs. 20.7 days, P = 0.03) and shortened the time (57.3 days vs. 70.5 days, P = 0.002) between the first admission and the reimplantation of a new prosthesis. The average cost of hospital stay ($8589.6 vs. $10,422.6, P = 0.021), antibiotics ($1052.2 vs. $1484.7, P = 0.032) and other medications ($691.5 vs. $1237.6, P = 0.014) per patient at our hospital were significantly decreased. Notably, significant improvements in patient satisfaction were seen in participants in the MR group. CONCLUSION: Through MR by clinical pharmacists, medication discrepancies within the orthopedic ERAS program could be identified. For patients with periprosthetic joint infection, better patient satisfaction and clinical and economical outcomes can be achieved with this method. BioMed Central 2022-04-06 /pmc/articles/PMC8985260/ /pubmed/35387676 http://dx.doi.org/10.1186/s12913-022-07884-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zheng, Xiaoying
Xiao, Lei
Li, Ying
Qiu, Feng
Huang, Wei
Li, Xinyu
Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
title Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
title_full Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
title_fullStr Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
title_full_unstemmed Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
title_short Improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
title_sort improving safety and efficacy with pharmacist medication reconciliation in orthopedic joint surgery within an enhanced recovery after surgery program
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985260/
https://www.ncbi.nlm.nih.gov/pubmed/35387676
http://dx.doi.org/10.1186/s12913-022-07884-9
work_keys_str_mv AT zhengxiaoying improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram
AT xiaolei improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram
AT liying improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram
AT qiufeng improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram
AT huangwei improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram
AT lixinyu improvingsafetyandefficacywithpharmacistmedicationreconciliationinorthopedicjointsurgerywithinanenhancedrecoveryaftersurgeryprogram